Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’

by Assad Shiti, Idit Goldfracht, Naim Shaheen, Stephanie Protze, Lior Gepstein
Published 2021-03-01

Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes

by Idit Goldfracht, Stephanie Protze, Assad Shiti, Noga Setter, Amit Gruber, Naim Shaheen, Yulia Nartiss, Gordon Keller, Lior Gepstein
Published 2020-01-01

Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes

by Sanam Shafaattalab, Eric Lin, Effimia Christidi, Haojun Huang, Yulia Nartiss, Analucia Garcia, Jeehon Lee, Stephanie Protze, Gordon Keller, Liam Brunham, Glen F. Tibbits, Zachary Laksman
Published 2019-05-01

Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue

by Zachary Laksman, Marianne Wauchop, Eric Lin, Stephanie Protze, Jeehoon Lee, Wallace Yang, Farzad Izaddoustdar, Sanam Shafaattalab, Lior Gepstein, Glen F. Tibbits, Gordon Keller, Peter H. Backx
Published 2017-07-01

Comparative transcriptional profiling of the axolotl limb identifies a tripartite regeneration-specific gene program.

by Dunja Knapp, Herbert Schulz, Cynthia Alexander Rascon, Michael Volkmer, Juliane Scholz, Eugen Nacu, Mu Le, Sergey Novozhilov, Akira Tazaki, Stephanie Protze, Tina Jacob, Norbert Hubner, Bianca Habermann, Elly M Tanaka
Published 2013-01-01

Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells

by Shunsuke Funakoshi, Ian Fernandes, Olya Mastikhina, Dan Wilkinson, Thinh Tran, Wahiba Dhahri, Amine Mazine, Donghe Yang, Benjamin Burnett, Jeehoon Lee, Stephanie Protze, Gary D. Bader, Sara S. Nunes, Michael Laflamme, Gordon Keller
Published 2021-05-01